Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation of T-cell responses to alloantigens by TR6/DcR3

1 Jun 2001

Abstract excerpt

TR6 (DcR3) is a new member of the TNF receptor (TNFR) family that lacks a transmembrane domain in its sequence, indicating that it is a secreted molecule. TR6 can bind to FasL and prevent FasL-induced apoptosis; it can also associate with LIGHT, another TNF family member. The role of TR6 in immune responses was investigated in this study. According to flow cytometry, recombinant human TR6-Fc binds to human LIGHT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Response and Inflammation
Share to RNA regulation and disease
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11390428
DOI: 10.1172/jci12159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation of T-cell responses to alloantigens by TR6/DcR3PMID 11390428Read ↗

Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis In Vitro and In VivoSemantic proximity Read ↗

Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.Semantic proximity Read ↗

Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.Semantic proximity Read ↗

Cutting Edge: FcR-Like 6 Is an MHC Class II ReceptorSemantic proximity Read ↗

Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cellsSemantic proximity Read ↗

Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expressionSemantic proximity Read ↗

Extracellular Isoforms of CD6 Generated by Alternative Splicing Regulate Targeting of CD6 to the Immunological SynapseSemantic proximity Read ↗

Treatment of Murine Lupus with TIGIT-IgSemantic proximity Read ↗

Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.Semantic proximity Read ↗

Characterization of the neutralizing activity of three anti-human TNF monoclonal antibodies and prediction of their TNF epitopes by molecular modeling and mutant protein approach.Semantic proximity Read ↗

TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.Semantic proximity Read ↗

Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.